Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 40.30
+0.25 (0.62%)
Aug 19, 2026, 5:35 PM CET
Dermapharm Holding SE Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,182 | 1,178 | 1,195 | 1,151 | 1,041 | 960.09 |
Revenue Growth | -1.42% | -1.43% | 3.89% | 10.59% | 8.38% | 18.78% |
Gross Profit Gross Profit Growth | 774.27 | 765.74 | 749.85 | 704.14 | 648.7 | 610.22 |
Operating Income Operating Income Growth | 242.91 | 236.62 | 222.07 | 193.16 | 282.72 | 295.91 |
Net Income Net Income Growth | 144.21 | 132.41 | 113.79 | 62.37 | 134.24 | 209.58 |
Earnings Per Share EPS Growth | 2.68 | 2.46 | 2.11 | 1.16 | 2.49 | 3.89 |
EPS Growth | 39.30% | 16.37% | 82.45% | -53.54% | -35.91% | 144.65% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Branded Pharmaceuticals Branded Pharmaceuticals Growth | 648 | 629.16 | 589.43 | 537.44 | 629.69 | - |
Other Healthcare Products Other Healthcare Products Growth | 361.7 | 363.84 | 369.96 | 402.33 | 180.67 | - |
Reconciliation/Group Holding Company Reconciliation/Group Holding Company Growth | -32.07 | -31.45 | -27.77 | -39.91 | -30.52 | -1.48 |
Parallel Import Business Parallel Import Business Growth | 190.76 | 203.44 | 249.15 | 235.49 | 244.94 | 230.63 |
Total Total Growth | 1,168 | 1,165 | 1,181 | 1,135 | 1,025 | 942.91 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 225.93 | 204.46 | 121.9 | 159.54 | 152.5 | 163.18 |
Total Debt Total Debt Growth | 1,039 | 1,058 | 990.26 | 1,094 | 516.45 | 580.3 |
Net Cash (Debt) Net Cash Growth | -813.54 | -853.46 | -868.36 | -934.03 | -363.95 | -417.13 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -15.12 | -15.85 | -16.13 | -17.35 | -6.76 | -7.75 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 284.74 | 229.15 | 201.38 | 219.42 | 288.53 | 250.37 |
Capital Expenditures CapEx Growth | -43.89 | -42.12 | -38.24 | -41.54 | -39.01 | -61.2 |
Free Cash Flow Free Cash Flow Growth | 240.85 | 187.03 | 163.14 | 177.88 | 249.52 | 189.17 |
Free Cash Flow Growth | 83.50% | 14.64% | -8.29% | -28.71% | 31.91% | 109.48% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 65.49% | 64.98% | 62.72% | 61.19% | 62.34% | 63.56% |
Operating Margin | 20.55% | 20.08% | 18.58% | 16.79% | 27.17% | 30.82% |
Pretax Margin | 16.52% | 15.57% | 14.39% | 9.21% | 20.79% | 30.52% |
Profit Margin | 12.20% | 11.24% | 9.52% | 5.42% | 12.90% | 21.83% |
FCF Margin | 20.37% | 15.87% | 13.65% | 15.46% | 23.98% | 19.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.880 | 0.880 | 0.900 | 0.880 | 1.050 | 2.170 |
Dividend Per Share Growth | -2.22% | -2.22% | 2.27% | -16.19% | -51.61% | 146.59% |
Dividend Yield | 2.20% | 2.28% | 2.42% | 2.23% | 3.07% | 2.79% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.04 | 16.00 | 18.41 | 36.55 | 15.05 | 22.94 |
Forward PE | 14.90 | 15.94 | 16.66 | 17.44 | 10.61 | 22.27 |
P/FCF Ratio | 8.29 | 11.33 | 12.84 | 12.82 | 8.10 | 25.42 |
PS Ratio | 1.69 | 1.80 | 1.75 | 1.98 | 1.94 | 5.01 |